Promethazine Vc
NDC 54868-3935
Product Information
Promethazine Vc is a ANDA-approved product labeled by Physicians Total Care, Inc.. See also Warning section. It is supplied as a yellow product. This product entry covers the primary NDC 54868-3935 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
Code Structure Chart
Product Details
What is NDC 54868-3935?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- PROMETHAZINE HYDROCHLORIDE (UNII: R61ZEH7I1I)
- PROMETHAZINE (UNII: FF28EJQ494) (Active Moiety)
- PHENYLEPHRINE HYDROCHLORIDE (UNII: 04JA59TNSJ)
- PHENYLEPHRINE (UNII: 1WS297W6MV) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- ALCOHOL (UNII: 3K9958V90M)
- ASCORBIC ACID (UNII: PQ6CK8PD0R)
- CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP)
- FD&C YELLOW NO. 6 (UNII: H77VEI93A8)
- MENTHOL (UNII: L7T10EIP3A)
- METHYLPARABEN (UNII: A2I8C7HI9T)
- PROPYLENE GLYCOL (UNII: 6DC9Q167V3)
- PROPYLPARABEN (UNII: Z8IX2SC1OH)
- WATER (UNII: 059QF0KO0R)
- SACCHARIN SODIUM DIHYDRATE (UNII: SB8ZUX40TY)
- SODIUM BENZOATE (UNII: OJ245FE5EU)
- SODIUM CITRATE (UNII: 1Q73Q2JULR)
- SUCROSE (UNII: C151H8M554)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 1248057 - phenylephrine HCl 5 MG / promethazine HCl 6.25 MG in 5 mL Oral Solution
- RxCUI: 1248057 - phenylephrine hydrochloride 1 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution
- RxCUI: 1248057 - phenylephrine hydrochloride 5 MG / promethazine hydrochloride 6.25 MG per 5 ML Oral Solution
* Please review the full disclaimer at the bottom of this page.